Established in 2019, the Institute of EndocrinologyMetabolism at the First Affiliated Hospital of University of South China was built upon the National Key Clinical Specialty in Endocrinology, the Hunan Clinical Research Center for Diabetes,the Hunan Clinical Research Center for Obesity PreventionTreatment. The Institute is dedicated to clinical managementresearch of common metabolic diseases such as diabetesobesity. In recent years, it has developed distinct research strengths in areas including diabetes, obesity,metabolic dysfunction-associated steatotic liver disease, exploring an innovative system that spans molecular mechanisms, biomarker discovery,clinical translation.

The Institute boasts a strong research team, including three doctoral supervisorsnine master supervisors, as well as 14 PhD holders. Among them, two are recipients of the Special Government Allowance of Hunan Province, one was selected as one of the first discipline leaders in Hunan higher education institutions,two are high-level medical discipline leaders under the Hunan Health Talent Plan. The Institute serves as a training base for masterdoctoral students in endocrinologymetabolism at University of South China. Currently, it hosts over 30 doctoralmaster students, forming a multi-level talent development system that includes master, doctoral,postdoctoral training.

In recent years, the Institute has led 25 national-level51 provincial-level research projects,has published significant findings in high-profile journals such as Cell Metabolism and Advanced Science. It has contributed to the development of expert consensusguidelines for metabolic diseases in China, promoting professional standardsprogress in the field. The Institute has also organizedparticipated in multiple nationalprovincial continuing medical education programs, significantly enhancing its disciplinary influence.

Adhering to the principle of “research-led, clinical translation,patient-centered service,” the Institute of EndocrinologyMetabolism will continue to address major national strategic needschallenging clinical issues. It aims to further strengthen innovative researchtechnological development, striving to build an influential researchclinical center for metabolic diseases both domesticallyinternationally,to provide solid scientifictalent support for the Healthy China initiative.

Academic Leader:

Xiao Xinhua, MD, Chief Physician, Professor,Doctoral Supervisor, is the Director of the Endocrinology Department. He serves as a National Committee Member of the Diabetes Branch of the Chinese Medical Association,is a recipient of the Special Government Allowance of Hunan Province. Recognized as a High-Level Medical Discipline Leader under the Hunan Provincial Health Talent Initiative, he has led five projects funded by the National Natural Science Foundation of China (NSFC).

Academic Pioneer:

Liu Jianghua, MD, is Chief Physician, Second-Class Professor,Doctoral Supervisor. He serves as a National Committee Member of the OsteoporosisBone Mineral Research Branch of the Chinese Medical Association. He is a recipient of the Special Government Allowance of Hunan Provincethe Hunan Provincial “Xu Teli Education Award,” and is recognized as a High-Level Medical Discipline Leader under the Hunan Provincial Health Talent Initiative. He has led four projects funded by the NSFCthe National Social Science Fund of China.

Chief Clinical Expert:

Liao Eryuan, MD, Chief Physician, Professor,Doctoral Supervisor, is honored as a “National Distinguished Medical Doctor.” He was a member of the FifthSixth Discipline Review Groups under the Academic Degrees Committee of the State Council. He has received multiple national awards, including the Second PrizeThird Prize of the National ScientificTechnological Progress Award.